Related references
Note: Only part of the references are listed.Different mechanisms of cisplatin resistance development in human lung cancer cells
Keisuke Okamoto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Anti-tumor effect of sulfasalazine in neuroblastoma
Marie R. Mooney et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Analysis of the effects of polyunsaturated fatty acids on transporter expressions using a PCR array: Induction of xCT/SLC7A11 in human placental BeWo cells
Kanako Ono et al.
PLACENTA (2019)
High expression of CD44v9 and xCT in chemoresistant hepatocellular carcinoma: Potential targets by sulfasalazine
Fumitaka Wada et al.
CANCER SCIENCE (2018)
Redox status in mammalian cells and stem cells during culture in vitro: Critical roles of Nrf2 and cystine transporter activity in the maintenance of redox balance
Tetsuro Ishii et al.
REDOX BIOLOGY (2014)
CD44 Variant Regulates Redox Status in Cancer Cells by Stabilizing the xCT Subunit of System xc- and Thereby Promotes Tumor Growth
Takatsugu Ishimoto et al.
CANCER CELL (2011)
The xc- cystine/glutamate antiporter:: A potential target for therapy of cancer and other diseases
Maisie Lo et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
Amino acid transport across mammalian intestinal and renal epithelia
Stefan Broer
PHYSIOLOGICAL REVIEWS (2008)
System xc- Activity and Astrocytes are necessary for interleukin-1β-mediated hypoxic neuronal injury
Birgit Fogal et al.
JOURNAL OF NEUROSCIENCE (2007)
Cystine and glutamate transport in renal epithelial cells transfected with human system xc-
CC Bridges et al.
KIDNEY INTERNATIONAL (2005)
Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the xc- cystine transporter:: a new action for an old drug
PW Gout et al.
LEUKEMIA (2001)
Share Paper
